Health Press Release – Newsletter for November 11, 2010

Five-Year Market Exclusivity for VYVANSE(R) Upheld

United States Court of Appeals for the District of Columbia Circuit Reaffirms NCE Exclusivity

PHILADELPHIA, November 10, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that the U.S. Court of Appeals for the
District of Columbia Circuit has affirmed the ruling of the U.S. District
Court for the District of Columbia and … Read the original article on Gaea Times at : Five-Year Market Exclusivity for VYVANSE(R) Upheld.

Elsevier to Publish Psychosomatics: Official Journal of the Academy of Psychosomatic Medicine

Publishing Partnership to Help Advance Excellence in Consultation-Liaison Psychiatry

NEW YORK, November 10, 2010 – Elsevier, the world's leading publisher of scientific, technical and
medical information, announced today that it is partnering with the Academy
of Psychosomatic Medicine (APM) to publish Psychosomatics, the official
journal of the Academy of Psychosomatic Medicine. The announcement, made at
the annual APM meeting …. Source  : Gaea News Network.

MarketsandMarkets: Worldwide Electronic Medical Records (EMR) Market to be US$ $9,957 Million By 2015

DALLAS, November 10, 2010 – The 'Worldwide Electronic Medical Records (EMR) Market, 2010-2015
(www.marketsandmarkets.com/Market-Reports/EMR-market-253.html )
(market share, winning strategies and adoption trends)' analyzes the EMR
market by end users, components and applications and studies the major market
drivers, restraints, and opportunities for the Electronic Medical Records
market in North America, Europe, Asia and ROW.

Browse market [..] Read the original article: here.

AB Therapeutics New Anticancer Compounds Reduce by 70% Lung Tumors Growth

The Barcelona Based Biotech Company is in a Series-A Fundraising Round to Conduct Preclinical Development and to File an IND in Late 2011

BARCELONA, November 10, 2010 – The Barcelona-based biotech company AB Therapeutics has obtained high
efficacy results with its 2 new anticancer compounds in animal models of lung
cancer (NSCLC) using Membrane Lipid Therapy (MLT), … Original article on : AB Therapeutics New Anticancer Compounds Reduce by 70% Lung Tumors Growth.

UNICEF Partners With frog design for Major mHealth Initiative

frog launches 'Mobile Mandate,' a new collaboration model to drive social innovation through mobile technology

SAN FRANCISCO, November 10, 2010 – frog design today announced a collaboration with UNICEF as the
organization's lead design and innovation partner on Project Mwana, a major
mHealth initiative to improve maternal and infant health and welfare in
peri-urban Malawi and rural Zambia. … Read : UNICEF Partners With frog design for Major mHealth Initiative.

Growth in Indian Pharma Market Reflected in Expected Record Numbers for CPhI, P-MEC, ICSE and BioPh India 2010 Events

Mumbai All Set for Biggest Ever Indian Pharma Event
AMSTERDAM, November 10, 2010 – Reflecting the rapid growth in the Indian Pharma market, leading events
organiser UBM Live today announced that it expects to see a record number of
attendees at its upcoming trade events, CPhI India for pharmaceutical
ingredients and intermediates, and co-located events, P-MEC for equipment … Read this article on Gaea Times at : Growth in Indian Pharma Market Reflected in Expected Record Numbers for CPhI, P-MEC, ICSE and BioPh India 2010 Events.

IIP Recognition for Trimega Laboratories

LONDON, November 10, 2010 – UK based Trimega Laboratories is pleased to announce that it has been
recognised as having met the standards set by the prestigious Investors in
People (IIP) Standard.

Its accreditation follows an examination by the Employer Representative
Quality Board of IIP and reflects the commitment and hard work undertaken by
Trimega … Read the original article on Gaea Times at : IIP Recognition for Trimega Laboratories.

Almac’s Clinical Technologies Business Unit Again Receives ‘Best Places to Work in PA 2010′ Award

SOUDERTON, Pennsylvania, November 10, 2010 – Almac's Clinical Technologies business unit, a part of the Almac Group,
has been named one of the Best Places to Work in PA for 2010. The awards
program, created in 2000, is one of the first statewide programs of its kind
in the country. The program is a public/private partnership between … Read : Almac's Clinical Technologies Business Unit Again Receives 'Best Places to Work in PA 2010' Award.

Waters Corporation Welcomes King’s College London into Waters Centers of Innovation Program

Aim is to Support the Drug Control Centre's Efforts to Develop Novel Analytical Methods for Sports Drug Testing and Toxicological Studies

MILFORD, Massachusetts, November 10, 2010 – Waters Corporation (NYSE: WAT) today welcomed into its Centers of
Innovation Program the Drug Control Centre within the Department of Forensic
Science and Drug Monitoring at King's College London.
…. Original article on Gaea Times at  : Waters Corporation Welcomes King's College London into Waters Centers of Innovation Program.

Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair

RICHMOND, Virginia, November 10, 2010 – Filtrona Porous Technologies, a custom developer and manufacturer of
medical grade foam and fiber components designed to absorb, retain, transfer,
filter or release fluids or vapors, will display an expanded range of
polyurethane foams and bonded fibers at the MEDICA / COMPAMED trade fair in
Dusseldorf, Germany from 17 to 19 November … Original source on Gaea Times at : Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair.

Inaccurate Reporting on Recent Omega-3 DHA Alzheimer’s Study Reveals Misrepresentation by Media

DARTMOUTH, Nova Scotia, November 10, 2010 – Several media outlets published articles last week suggesting that
Omega-3 fish oil supplements fail to show positive results for Alzheimer's
patients. This reporting by media outlets came after the Journal of the
American Medical Association (JAMA) published the study "Docosahexaenoic Acid
Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized
Trial", where …. Source article on Gaea Times at  : Inaccurate Reporting on Recent Omega-3 DHA Alzheimer's Study Reveals Misrepresentation by Media.

Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder

ANTONY, France, November 10, 2010 – Following the announcement that Wendel had entered exclusive
negotiations with Ares Life Sciences on October 28, 2010, with a view to
selling its entire stake (around 46%) in Stallergenes, the company's Works
Council met on November 10, 2010.

Stallergenes' Works Council having returned a positive
consultative opinion at this … Original article on : Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder.